deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02863354

Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy (RECOVERY)

Sponsor: Charles C Wykoff, PhD, MD

Conditions Proliferative Diabetic Retinopathy
Interventions Aflibercept
Updated 12 times since 2017 Last updated: May 20, 2021 Started: Aug 31, 2016 Primary completion: May 31, 2019 Completion: May 31, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Proliferative Diabetic Retinopathy, this trial is completed. The trial is conducted by Charles C Wykoff, PhD, MD and has accumulated 12 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshotRecruiting~Mar 2017 – ~Oct 2017 · 7 months · monthly snapshotRecruiting~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshotActive Not Recruiting~Feb 2019 – ~Jan 2021 · 23 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshotActive Not Recruiting~Feb 2021 – ~May 2021 · 3 months · monthly snapshotUnknown Status~May 2021 – ~Jun 2021 · 31 days · monthly snapshotCompleted~Jun 2021 – ~Jul 2024 · 37 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jun 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. May 2021 — Jun 2021 [monthly]

    Completed PHASE2

    Status: Unknown Status → Completed

  5. Feb 2021 — May 2021 [monthly]

    Unknown Status PHASE2

    Status: Active Not Recruiting → Unknown Status

▶ Show 7 earlier versions

  1. Jan 2021 — Feb 2021 [monthly]

    Active Not Recruiting PHASE2

  2. Feb 2019 — Jan 2021 [monthly]

    Active Not Recruiting PHASE2

  3. Jun 2018 — Feb 2019 [monthly]

    Active Not Recruiting PHASE2

  4. Oct 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  5. Mar 2017 — Oct 2017 [monthly]

    Recruiting PHASE2

  6. Feb 2017 — Mar 2017 [monthly]

    Recruiting PHASE2

  7. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Charles C Wykoff, PhD, MD
  • Regeneron Pharmaceuticals
Data source: Greater Houston Retina Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations